What 6 Analyst Ratings Have To Say About Revolution Medicines
Portfolio Pulse from Benzinga Insights
In the last quarter, 6 analysts have provided ratings for Revolution Medicines (NASDAQ:RVMD), with 5 being bullish, 1 somewhat bullish, and none being bearish or indifferent. The company has an average 12-month price target of $38.0, with a high of $47.00 and a low of $32.00. The average price target has increased by 2.7% over the past month.
November 07, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Revolution Medicines has received predominantly bullish ratings from analysts, with an increasing average price target. This could indicate positive sentiment and potential upward movement in the short term.
Analyst ratings are a significant factor in stock performance. The predominantly bullish ratings for Revolution Medicines, along with an increasing average price target, suggest analysts expect the stock to perform well. This could lead to increased investor confidence and potential upward price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100